[HTML][HTML] Durability of transgene expression after rAAV gene therapy

M Muhuri, DI Levy, M Schulz, D McCarty, G Gao - Molecular Therapy, 2022 - cell.com
Recombinant adeno-associated virus (rAAV) gene therapy has the potential to transform the
lives of patients with certain genetic disorders by increasing or restoring function to affected …

Durability of transgene expression after rAAV gene therapy

M Muhuri, DI Levy, M Schulz… - … therapy: the journal …, 2022 - pubmed.ncbi.nlm.nih.gov
Recombinant adeno-associated virus (rAAV) gene therapy has the potential to transform the
lives of patients with certain genetic disorders by increasing or restoring function to affected …

Durability of transgene expression after rAAV gene therapy

M Muhuri, DI Levy, M Schulz… - Molecular …, 2022 - repository.escholarship.umassmed …
Recombinant adeno-associated virus (rAAV) gene therapy has the potential to transform the
lives of patients with certain genetic disorders by increasing or restoring function to affected …

[HTML][HTML] Durability of transgene expression after rAAV gene therapy

M Muhuri, DI Levy, M Schulz, D McCarty, G Gao - Molecular Therapy, 2022 - Elsevier
Recombinant adeno-associated virus (rAAV) gene therapy has the potential to transform the
lives of patients with certain genetic disorders by increasing or restoring function to affected …

[HTML][HTML] Durability of transgene expression after rAAV gene therapy

M Muhuri, DI Levy, M Schulz, D McCarty… - Molecular …, 2022 - ncbi.nlm.nih.gov
Recombinant adeno-associated virus (rAAV) gene therapy has the potential to transform the
lives of patients with certain genetic disorders by increasing or restoring function to affected …

Durability of transgene expression after rAAV gene therapy.

M Muhuri, DI Levy, M Schulz, D McCarty… - Molecular Therapy: the …, 2022 - europepmc.org
Recombinant adeno-associated virus (rAAV) gene therapy has the potential to transform the
lives of patients with certain genetic disorders by increasing or restoring function to affected …

Durability of transgene expression after rAAV gene therapy.

M Muhuri, DI Levy, M Schulz, D McCarty… - Molecular Therapy: the …, 2022 - europepmc.org
Recombinant adeno-associated virus (rAAV) gene therapy has the potential to transform the
lives of patients with certain genetic disorders by increasing or restoring function to affected …